Triple-negative breast cancer (TNBC), a highly aggressive subtype of breast cancer,
negatively expresses estrogen receptor, progesterone receptor, and the human epidermal …

Breast cancer is the most common malignancy in women worldwide and is associated with
high mortality rates despite the continuously advancing treatment strategies. Glucose is …

Radiotherapy (RT) is one of the important clinical treatments for local control of triple-
negative breast cancer (TNBC), but radioresistance still exists. Ferroptosis has been …

Immune-checkpoint inhibitors (ICI) are promising modalities for treating triple negative
breast cancer (TNBC). However, hyperglycolysis, a hallmark of TNBC cells, may drive tumor …

The functional status of innate immune cells is a considerable determinant of effective
antitumor immune response. However, the triple-negative breast cancer tumor …

Triple negative tumors represent 15% of breast cancer and are characterized by the lack of
estrogen receptors, progesterone receptor, and HER2 amplification or overexpression …

Purpose The m5C RNA methylation regulators are closely related to tumor proliferation,
occurrence, and metastasis. This study aimed to investigate the gene expression …

Triple negative breast cancer (TNBC) is a subtype of breast cancer, with estrogen receptor,
human epidermal growth factor receptor 2 and progesterone receptor negative. TNBC is …

Triple negative breast cancer (TNBC) with easy metastasis,“cold” tumor immune
microenvironment, and lack of targeted therapy remains poorly prognosed. Chemo …

Triple-negative breast cancer (TNBC) due to lack of clear target and notorious “cold” tumor
microenvironment (TME) is one of the most intractable and lethal malignancies. Tuning …